High-altitude cerebral edema evaluated with magnetic resonance imaging. Clinical correlation and pathophysiology

JAMA

Volumn 280, Issue 22, 1998, Pages 1920-1925

  Hackett, Peter H ^a,b,c,e   Yarnell, Philip R ^d   Hill, Richard ^b   Reynard, Kenneth ^d   Heit, Joseph ^d   McCormick, John ^b  

^a UNIVERSITY OF ALASKA ANCHORAGE   (United States)

^b Alaska Regional Hospital   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^e St Mary's Hospital Grand Junction   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALTITUDE DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; FOLLOW UP; HUMAN; LUNG EDEMA; MALE; MOUNTAINEERING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SKIING; UNITED STATES; WHITE MATTER;

EID: 0032501354     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.22.1920     Document Type: Article

References (43)

1. Singh I, Khanna PK, Srivastava MC, Lal M, Roy SB. Acute mountain sickness. N Engl J Med. 1969; 280:175-218.
2. Houston CS, Dickinson JG. Cerebral form of high altitude illness. Lancet. 1975;2:758-761.
3. Hackett PH, Rennie ID, Levine HO. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 1976;2:1149-1154.
4. Klatzo I. Presidential address: neuropathologic aspect of brain edema. J Neuropathol Exp Neurol. 1967;26:1-14.
5. Fishman RA. Brain edema. N Engl J Med. 1975; 293:706-711.
6. Hansen JE, Evans WO. A hypothesis regarding the pathophysiology of acute mountain sickness. Arch Environ Health. 1970;21:666-669.
7. Lassen NA, Harper AM. High altitude cerebral oedema. Lancet. 1975;2:1154.
8. Sutton JR, Lassen NA. Pathophysiology of acute mountain sickness and high altitude pulmonary edema: an hypothesis. Bull Eur Physiopathol Respir. 1979;15:1045-1052.
9. Wohns RN. High altitude cerebral edema: a pathophysiological review. Crit Care Med. 1981;9: 880-882.
10. Dickinson JG, Heath J, Gosney J, Williams D. Altitude related deaths in seven trekkers in the Himalayas. Thorax. 1983;38:646-656.
11. Krasney J. Cerebral hemodynamics and high altitude cerebral edema. In: Houston C, Coates G, eds. Hypoxia: Women at Altitude. Burlington, Vt: Queen City Press; 1997:254-268.
12. Klatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol (Berl). 1987;72:236-239.
13. Bradley WB. Pathophysiologic correlates of signal alteration. In: Brant-Zawadzki M, Norman D, eds. Magnetic Resonance Imaging of the Central Nervous System. New York, NY: Raven Press; 1987:29-33.
14. Kobayashi T, Koyoma S, Kubo K, Fukushima M, Kusama S. Clinical features of patients with high altitude pulmonary edema in Japan. Chest. 1987;92: 814-821.
15. Levine B, Yoshimura K, Kobayashi T, Fukushima M, Shibamoto T, Ueda G. Dexamethasone in the treatment of acute mountain sickness. N Engl J Med. 1989;321:1707-1713.
16. Roach RC, Bartsch P, Oelz O, Hackett PH. The Lake Louise acute mountain sickness scoring system. In: Sutton JR, Coates G, Houston CS, eds. Hypoxia and Molecular Medicine. Burlington, Vt: Queen City Press; 1993:272-274.
17. Matsuzawa Y, Kobayashi T, Fujimoto K, et al. Cerebral edema in acute mountain sickness. In: Ueda G, Reeves JT, Sekiguchi M, eds. High Altitude Medicine. Matsumoto, Japan: Shinshu University Press; 1992:300-304.
18. Zavasky DM, Hackett PH. Cerebral etiology of acute mountain sickness: MRI findings [abstract]. Wilderness Environ Med. 1995;6:229-230.
19. Yamaguchi S, Kobayashi T, Matsuzawa Y, et al. MRI findings in patients with high altitude pulmonary edema. In: Ueda G, Reeves JT, Sekiguchi M, eds. High Altitude Medicine. Matsumoto, Japan: Shinshu University Press; 1992:305-308.
20. Garrido E, Castello A, Ventura JL, et al. Cortical atrophy and other brain magnetic resonance imaging (MRI) changes after extremely high altitude climbs without oxygen. Int J Sports Med. 1993; 14:232-234.
21. Garrido E, Segura R, Capdevila A, et al. New evidence from magnetic resonance imaging of brain changes after climbs at extreme altitude. Eur J Appl Physiol. 1995;70:447-481.
22. Simonson TM, Yuh WTC. Stroke and cerebral ischemia. In: Edelman RR, Zlatkin MB, Hesselink JR, eds. Clinical Magnetic Resonance Imaging. 2nd ed. Philadelphia, Pa: WB Saunders Co; 1996:767-773.
23. Moody DM, Bell MA, Challa VR. The corpus callosum, a unique white matter tract: anatomic features that may explain sparing in Binswanger disease and resistance to flow of fluid masses. AJNR Am J Neuroradiol. 1988;9:1051-1059.
24. Ito T, Sakai T, Inagawa S, Utsu M, Bun T. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol. 1995;16:1344-1346.
25. Cordoliani Y-S, Sarrazin J-L, Felten D, Caumes E, Leveque C, Fisch A. MR of cerebral malaria. AJNR Am J Neuroradiol. 1998;9:871-874.
26. Le Bihan D, Turner R. Diffusion and perfusion. In: Stark DD, Bradley WG, eds. Magnetic Resonance Imaging. 2nd ed. St Louis, Mo: Mosby-Year Book Inc; 1992:335-369.
27. Moody DM, Bell MA, Challa VR. Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol. 1990;11: 431-439.
28. Ferrazzini G, Maggiorini M, Kriemler S, Bartsch P, Oelz O. Successful treatment of acute mountain sickness with dexamethasone. BMJ. 1987;294: 1380-1382.
29. Hackett PH, Roach RC, Wood RA, et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med. 1988; 59:950-954.
30. Hackett PH, Roach RC. High altitude medicine. In: Auerbach PS, ed. Wilderness Medicine, Management of Wilderness and Environmental Emergencies. St Louis, Mo: Mosby-Year Book Inc; 1995: 1-37.
31. Joo F, Klatzo I. Role of cerebral endothelium in brain oedema. Neurol Res. 1989;11:67-75.
32. Greenwood J, Begley DJ, Segal MB, eds. New Concepts of a Blood-Brain Barrier. New York, NY: Plenum Press; 1995.
33. Hauser RA, Lacey DM, Knight MR. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45:1078-1083.
34. Raroque HG, Orrison WW, Rosenberg GA. Neurologic involvement in toxemia of pregnancy: reversible MRI lesions. Neurology. 1990;40:167-169.
35. Yaffe K, Ferriero D, Barkovich J, Rowley H. Reversible MRI abnormalities following seizures. Neurology. 1995;45:104-108.
36. Baumgartner RW, Spyridopoulos I, Bartsch P, Maggiorini M, Oelz O. Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study. J Appl Physiol. In press.
37. Krasney JA. A neurogenic basis for acute altitude illness. Med Sci Sports Exerc. 1994;26:195-208.
38. Schilling L, Wahl M. Brain edema: pathogenesis and therapy. Kidney Int. 1997;51(suppl59):S69-S75.
39. Plateel M, Dehouck M-P, Torpier G, Cecchelli R, Tessier E. Hypoxia increases the susceptibility to oxidant stress and the permeability of the blood-brain barrier endothelial cell monolayer. J Neurochem. 1995;65:2138-2145.
40. Bartsch P, Shaw S, Francioli M, Gnadinger MP, Weidmann P. Atrial naturetic peptide in acute mountain sickness. J Appl Physiol. 1988;65:1929-1937.
41. Richalet JP, Hormych A, Rathat C, Aumont J, Larmignant P, Remy P. Plasma prostaglandins, leukotrienes and thromboxane in acute high altitude hypoxia. Respir Physiol. 1991;85:205-215.
42. Severinghaus JW. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high altitude cerebral edema. J Appl Physiol. 1995;79:375-379.
43. Ogawa S, Koga S, Kuwabara R, et al. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am J Physiol. 1992;262:C546-C554.